Status:
COMPLETED
Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer
Lead Sponsor:
Laboratoires Thea
Conditions:
Keratitis
Corneal Ulcer
Eligibility:
All Genders
18-95 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the efficacy and safety of T4020 versus vehicle.
Eligibility Criteria
Inclusion
- Adult patients diagnosed with one chronic keratitis/corneal ulcer
- Patients who signed and dated informed consent
Exclusion
- Patient under 18 years
- Patient with a perforated corneal ulcer OR any risk of immediate perforation of corneal ulcer.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2017
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT01794312
Start Date
February 1 2013
End Date
December 19 2017
Last Update
October 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Development Director
Clermont-Ferrand, France, 63000